- Friday, September 18: Thomas M. Seed, PhD, Principal Consultant, Tech Micro Services, Bethesda, MD: Canine model for chronic radiation health effects. Related information:
- Friday, September 11: Yufang Shi, PhD, Professor, Department of Molecular Genetics, Microbiology and Immunology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ: NO links mesenchymal stem cells to immunosuppression. Related information:
- Friday, September 4: Merriline M. Satyamitra, PhD, Research Scientist (HMJF), Radiation Countermeasures Program, AFRRI: Evaluation of radiation countermeasures under NIAID-AFRRI inter agency agreement (IAA). Related Information:
- Friday, July 24: Lynnette Cary, PhD, Scientist (Henry M. Jackson Foundation), Radiation Countermeasures Program, AFRRI: Endothelial cells exposed to neutron/gamma mixed field radiation secrete factors involved in chemotaxis, angiogenesis, and cell survival. Related information:
- Friday, July 17: Ian A. Gifford, PhD, Nuclear Engineer, AFRRI: Boron neutron capture therapy at the Maryland University Training Reactor (MUTR). Related information:
- Friday, July 10: Juliann G. Kiang, PhD, Senior Principal Investigator, Combined Injury Program, AFRRI; Professor of Radiation Biology, Pharmacology, and Medicine, School of Medicine, USUHS: Wound trauma enhanced ionizing radiation-induced mortality: Roles of iNOS, cytokines, and bacterial infection. Related information:
- Friday, June 26: Vijay K. Singh, PhD, Department of Radiation Biology, F. Edward Hebért School of Medicine USUHS; Radiation Countermeasure Program, AFRRI: Progress toward a radiation countermeasure that is effective when initiated days after irradiation. Related information:
- Friday, June 12 (noon–1 p.m.): Joseph Mattapallil, PhD, Assistant Professor, Department of Microbiology and Immunology, F. Edward Hebért School of Medicine, USUHS: Host modulation of acute HIV infection: lessons from the non-human primate model. Related information:
- Friday, May 29: Yogendra Singh, PhD, Visiting Scientist, Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Md.; Scientist G, Institute of Genomics and Integrative Biology, Delhi, India: Protein kinases and phosphatases of mycobacterium tuberculosis. Related information:
- Friday, May 15: Fung-Lung Chung, PhD, Professor, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC: Lung cancer chemprevention by isothiocyanates: From laboratory to human. Related information:
- Friday, May 8: Thomas B. Elliott, PhD, Research Microbiologist, Combined Injury Program, AFRRI: Susceptibility and cytokine responses to infections after ionizing irradiation. Related information:
- Friday, May 1: Mukesh Verma, PhD, Chief, Methods and Technologies Branch, Program Director, Epidemiology and Genetics Research Program, Division of Cancer Control and Population Sciences. National Cancer Institute, NIH, Bethesda, Md.: Epigenetics approaches in cancer epidemiology. Related information:
- Friday, April 24: Sanchita P. Ghosh, PhD, Research Investigator, Henry M. Jackson Foundation (Radiation Countermeasures Program, AFRRI), Bethesda, Md.: Mechanisms of radiation protection by gamma-tocotrienol. Related information:
- Friday, April 10: Subrata Sinha, MD, PhD, Professor and Head, Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India: Determinants of glial tumor heterogeneity: Molecular features and the microenvironment. Related information:
- Friday, April 3: Michael Graham Espey, PhD, Staff Scientist, Molecular & Clinical Nutrition Section, Digestive Disease Branch, National Institute of Diabetes Digestive and Kidney Diseases, NIH, Bethesda, Md.: Quercetin and glucose transport in the small intestine. Related information:
- Friday, March 27: William F. Blakely, PhD, Program Advisor, Biological Dosimetry, AFRRI: Early biodosimetry response: Recommendations for mass-casualty radiation accidents and terrorism. Related information:
- Friday, March 20: Gregory L. King, PhD, Research Physiologist, Radiation Infection Treatment Program, AFRRI: The rat as an animal model for radiation-induced GI mucositis. Related information:
- Early-expression and non-invasive biomarkers of acute radiation syndrome, NATO HFM-099/RTG-099, June 2007, Annual Meeting, Brno, Czech Republic.
- Sublethal gamma-radiation decreases resistance of mice to oral Shigella sonnei challenge. Microbial Ecol Health Dis., 14: 179–90, 2002.
- Nuclear, biological, and chemical combined injuries and countermeasures on the battlefield. Mil Med., 167:95–7, 2002.
- Friday, March 13: John F. Kalinich, PhD, Program Advisor, Internal Contamination and Metal Toxicity Program, AFRRI: Determination of radiation exposure using urinary biomarkers. Related information:
- Friday, March 6: Michael R. Landauer, PhD, Research Toxicologist, AFRRI: Radioprotection by genistein: mechanisms of action. Related information:
- Friday, February 27: G. David Ledney, PhD, Research Biologist, Radiation Combined Injury Program, AFRRI: Combined injury: treatment and radiation dose determination challenges. Related information:
- Retrospective analyses of serum lipids and lipoproteins and severity of disease in 60Co-irradiated Sus scrofa domestica and Macaca mulatta. Comp. Med., 57:298–304, 2007
- Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis. Report of an NIAID Workshop, March 26–27, 2007. Radiat. Res., 169: 712–721, 2008.
- Antibacterial activity of the soy isoflavone genistein. J Basic Microbiol., 46:329–35, 2006.
- Friday, February 20: K.S. Kumar, PhD, Research Chemist, Radiation Countermeasures, AFRRI: Radiation countermeasure studies with tocols. Related information:
- Friday, February 13: Pataje G.S. Prasanna, PhD, Research Biologist, AFRRI: Cytogenetic biodosimetry at the Armed Forces Radiobiology Research Institute. Related information:
- Friday, February 6: Venkataraman Srinivasan, PhD, Research Biologist, Radiation Countermeasure Program, AFRRI: Delta tocotrienol as a radiation countermeasure. Related information:
- Friday, January 30: Anu Puri, PhD, Research Biologist, CCR Nanobiology Program, NIH, NCI-Frederick, Frederick, Md.: Lipid-based nanoparticles for sustained, targeted, and localized delivery of cancer therapeutics. Related information:
- Friday, January 23: Richard N. Kolesnick, MD, Associate Member, Molecular Pharmacology and Therapeutics Program, Sloan-Kettering Institute, N.Y.: Radiation-induced GI and bone marrow damage: two events or three? Related information:
- Friday, January 16: Barrett N. Fountos, MS, Program Manager/Health Scientist, Office of International Health Studies, U.S. Department of Energy (DOE), Germantown, Md.: History and relevance of the Russian health studies program. Related information:
|